SART3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.531800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.509000E-01
Normal-vs-Stage2
3.097000E-01
Normal-vs-Stage3
1.059780E-01
Normal-vs-Stage4
6.375200E-01
Stage1-vs-Stage2
1.952830E-01
Stage1-vs-Stage3
3.648100E-02
Stage1-vs-Stage4
5.836400E-01
Stage2-vs-Stage3
5.135900E-02
Stage2-vs-Stage4
7.008000E-01
Stage3-vs-Stage4
3.037800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.844200E-01
Normal-vs-AfricanAmerican
5.111200E-01
Normal-vs-Asian
1.492040E-01
Caucasian-vs-AfricanAmerican
9.217600E-01
Caucasian-vs-Asian
9.067900E-02
AfricanAmerican-vs-Asian
3.290000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.306000E-01
Normal-vs-Female
2.849800E-01
Male-vs-Female
4.016400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.151800E-01
Normal-vs-Age(41-60Yrs)
6.109600E-01
Normal-vs-Age(61-80Yrs)
2.487400E-01
Normal-vs-Age(81-100Yrs)
4.454000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.483000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.715640E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.450800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.304600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.948000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.624800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.676160E-01
Normal-vs-Daily Drinker
3.084000E-01
Normal-vs-Weekly Drinker
4.066000E-01
Normal-vs-Occasional Drinker
7.622200E-01
Normal-vs-Social Drinker
5.101600E-01
Non Drinker-vs-Daily Drinker
4.926000E-01
Non Drinker-vs-Weekly Drinker
6.319600E-01
Non Drinker-vs-Occasional Drinker
3.125700E-02
Non Drinker-vs-Social Drinker
1.380580E-01
Daily Drinker-vs-Weekly Drinker
9.487200E-01
Daily Drinker-vs-Occasional Drinker
1.537830E-01
Daily Drinker-vs-Social Drinker
4.222200E-01
Weekly Drinker-vs-Occasional Drinker
2.306400E-01
Weekly Drinker-vs-Social Drinker
4.836000E-01
Occasional Drinker-vs-Social Drinker
5.399800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.405600E-01
Normal-vs-Grade 2
5.983000E-01
Normal-vs-Grade 3
5.723800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.548800E-01
Grade 1-vs-Grade 3
9.418800E-01
Grade 1-vs-Grade 4
2.405600E-01
Grade 2-vs-Grade 3
4.992600E-01
Grade 2-vs-Grade 4
5.983000E-01
Grade 3-vs-Grade 4
5.723800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.388400E-01
Normal-vs-NonDiabetic
3.598400E-01
Diabetic-vs-NonDiabetic
3.922800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.471400E-01
Normal-vs-NoPancreatitis
3.496800E-01
Pancreatitis-vs-NoPancreatitis
6.626600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.679800E-01
Normal-vs-N1
3.391000E-01
N0-vs-N1
9.201400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.560800E-01
Normal-vs-TP53-NonMutant
6.434800E-01
TP53-Mutant-vs-TP53-NonMutant
6.531600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
